Cough in pediatric patients receiving angiotensin-converting enzyme inhibitor therapy or angiotensin receptor blocker therapy in randomized controlled trials

Clinical Pharmacology and Therapeutics

Volumn 87, Issue 6, 2010, Pages 668-671

  Baker Smith, C M ^a,b   Benjamin Jr , D K ^a,b,c   Califf, R M ^a,b   Murphy, M D ^c   Li, J S ^a,b,c   Smith, P B ^a,b,c  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BENAZEPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; IRBESARTAN; LISINOPRIL; LOSARTAN; PLACEBO; QUINAPRIL; RAMIPRIL;

ARTICLE; CLINICAL TRIAL; COUGHING; DATA ANALYSIS; HUMAN; HYPERTENSION; META ANALYSIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHILD; COUGH; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; MALE; PREVALENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77952585357     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2009.231     Document Type: Article

References (10)

1. Matchar, D.B. et al. Systematic review: comparative efectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension. Ann. Intern. Med. 148, 16-29 (2008).
2. Brown, N.J. & Vaughan, D.E. Angiotensin-converting enzyme inhibitors. Circulation 97, 1411-1420 (1998).
3. Bianchetti, M.G., Cafisch, M. & Oetliker, O.H. Cough and converting enzyme inhibitors. Eur. J. Pediatr. 151, 225-226 (1992).
4. Seeman, T., Dusek, J., Vondrák, K., Flögelová, H., Geier, P. & Janda, J. Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases. Am. J. Hypertens. 17, 415-420 (2004).
5. Malacco, E. et al.; Blood Pressure Reduction and Tolerability of Valsartan in Comparison with Lisinopril Study. Comparison of valsartan 160 mg with lisinopril 20 mg, given as monotherapy or in combination with a diuretic, for the treatment of hypertension: the Blood Pressure Reduction and Tolerability of Valsartan in Comparison with Lisinopril (PREVAIL) study. Clin. Ther. 26, 855-865 (2004). (Pubitemid 38943034)
6. Os, I., Bratland, B., Dahlöf, B., Gisholt, K., Syvertsen, J.O. & Tretli, S. Female preponderance for lisinopril-induced cough in hypertension. Am. J. Hypertens. 7, 1012-1015 (1994).
7. Morimoto, T. et al. Development and validation of a clinical prediction rule for angiotensin-converting enzyme inhibitor-induced cough. J. Gen. Intern. Med. 19, 684-691 (2004).
8. Ravid, D., Lishner, M., Lang, R. & Ravid, M. Angiotensin-converting enzyme inhibitors and cough: a prospective evaluation in hypertension and in congestive heart failure. J. Clin. Pharmacol. 34, 1116-1120 (1994).
9. Israili, Z.H. & Hall, W.D. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann. Intern. Med. 117, 234-242 (1992).
10. Jafe, I.A. Adverse efects profle of sulfhydryl compounds in man. Am. J. Med. 80, 471-476 (1986).